0001527599-11-000001.txt : 20110823
0001527599-11-000001.hdr.sgml : 20110823
20110823120203
ACCESSION NUMBER: 0001527599-11-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506
FILED AS OF DATE: 20110823
DATE AS OF CHANGE: 20110823
EFFECTIVENESS DATE: 20110823
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mirna Therapeutics, Inc.
CENTRAL INDEX KEY: 0001527599
IRS NUMBER: 261824804
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-164825
FILM NUMBER: 111051520
BUSINESS ADDRESS:
STREET 1: 2150 WOODWARD ST., SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78744
BUSINESS PHONE: 512-681-5252
MAIL ADDRESS:
STREET 1: 2150 WOODWARD ST., SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78744
D
1
primary_doc.xml
X0704
D
LIVE
0001527599
Mirna Therapeutics, Inc.
2150 WOODWARD ST., SUITE 100
AUSTIN
TX
TEXAS
78744
512-681-5200
DELAWARE
None
None
Corporation
true
2007
Paul
Lammers
2150 Woodward St., Suite 100
Austin
TX
TEXAS
78744
Executive Officer
Director
Matthew
M
Winkler
2150 Woodward St., Suite 100
Austin
TX
TEXAS
78744
Director
Christopher
D
Earl
2150 Woodward St., Suite 100
Austin
TX
TEXAS
78744
Director
Evan
S
Melrose
2150 Woodward St., Suite 100
Austin
TX
TEXAS
78744
Director
Corey
S
Goodman
2150 Woodward St., Suite 100
Austin
TX
TEXAS
78744
Director
Lynne
Hohlfeld
2150 Woodward St., Suite 100
Austin
TX
TEXAS
78744
Executive Officer
Ana
C
Ward
2150 Woodward St., Suite 100
Austin
TX
TEXAS
78744
Executive Officer
Biotechnology
Decline to Disclose
- 06
false
2011-08-10
false
true
false
0
1500000
1500000
0
false
9
0
0
0
false
Mirna Therapeutics, Inc.
/s/ Lynne Hohlfeld
Lynne Hohlfeld
Chief Financial Officer & Secretary
2011-08-23